| Clay Daniel Holley, MD | |
|
3417 Busch St, Butte, MT 59701-3505 | |
| (406) 494-3145 | |
| Not Available |
| Full Name | Clay Daniel Holley |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 14 Years |
| Location | 3417 Busch St, Butte, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346565330 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | BP10041198 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rocky Mountain Eye Center Pc | 7416986542 | 15 |
News Archive
A new study finds wide state-by-state variations in Medicaid reimbursements to physicians who treat cancer patients with radiation therapies.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
America's Health Insurance Plans on Tuesday launched a new grassroots campaign designed "to build support for workable health care reform based on core principles shared by the American people: coverage, affordability, quality, value, choice and portability," the organization said, CQ HealthBeat reports.
Scientists are constantly on the hunt for treatments that can selectively target cancer cells, leaving other cells in our bodies unharmed.
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.
› Verified 1 days ago
| Entity Name | Rocky Mountain Eye Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740291350 PECOS PAC ID: 7416986542 Enrollment ID: O20050809001023 |
News Archive
A new study finds wide state-by-state variations in Medicaid reimbursements to physicians who treat cancer patients with radiation therapies.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
America's Health Insurance Plans on Tuesday launched a new grassroots campaign designed "to build support for workable health care reform based on core principles shared by the American people: coverage, affordability, quality, value, choice and portability," the organization said, CQ HealthBeat reports.
Scientists are constantly on the hunt for treatments that can selectively target cancer cells, leaving other cells in our bodies unharmed.
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clay Daniel Holley, MD Po Box 4907, Missoula, MT 59806-4907 Ph: (406) 541-3937 | Clay Daniel Holley, MD 3417 Busch St, Butte, MT 59701-3505 Ph: (406) 494-3145 |
News Archive
A new study finds wide state-by-state variations in Medicaid reimbursements to physicians who treat cancer patients with radiation therapies.
Depomed, Inc. today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1796 for postherpetic neuralgia (PHN) held in December 2009. Depomed also commented on recent public disclosures related to the Complete Response letter from the U.S. Food and Drug Administration regarding the New Drug Application (NDA) for Horizant™ (gabapentin enacarbil) Extended-Release Tablets.
America's Health Insurance Plans on Tuesday launched a new grassroots campaign designed "to build support for workable health care reform based on core principles shared by the American people: coverage, affordability, quality, value, choice and portability," the organization said, CQ HealthBeat reports.
Scientists are constantly on the hunt for treatments that can selectively target cancer cells, leaving other cells in our bodies unharmed.
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.
› Verified 1 days ago
Bartholomew Andrew Martyak, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3417 Busch St, Butte, MT 59701 Phone: 406-541-3937 Fax: 406-541-1810 | |
Dr. Robert Ian Noble, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 832 S Montana St, Butte, MT 59701 Phone: 406-723-4004 | |
Dr. David G Shapnick, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Butte, MT 59701 Phone: 406-782-3808 Fax: 406-782-3802 | |
Dr. Richard T Tschetter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 832 S Montana St, Butte, MT 59701 Phone: 406-723-4004 Fax: 406-782-4567 |